Brief: OrthoPediatrics Posts Q4 Loss Per Share $0.35
28/02/2023 21:11
Feb 28 (Reuters) - OrthoPediatrics Q4 adjusted EBITDA USD -2.2 million. * Q4 EPS USD -0.35 * Q4 net income USD -7.8 million * Q4 gross margin 68.5% * Outlook FY revenue USD 146-149 million
Recent news on Orthopediatrics
See all newsOrthoPediatrics Corp reports results for the quarter ended June 30 - Earnings Summary
OrthoPediatrics Q2 revenue rises 15%, beats estimates
Brief: OrthoPediatrics Q2 EPS USD -0.3
OrthoPediatrics Corp expected to post a loss of 30 cents a share - Earnings Preview
OrthoPediatrics beats Q1 revenue estimates, raises 2026 outlook